Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pivotal Study to Assess the Safety and Effectiveness of NovoSorb® Biodegradable Temporizing Matrix (BTM) in the Treatment of Severe Burn Skin Injuries

NCT04090424 is registered in ClinicalTrials.gov with PolyNovo Biomaterials Pty Ltd. as lead sponsor.

NCT NCT04090424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04090424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pivotal Study to Assess the Safety and Effectiveness of NovoSorb® Biodegradable Temporizing Matrix (BTM) in the Treatment of Severe Burn Skin Injuries
Lead sponsor
PolyNovo Biomaterials Pty Ltd.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 21, 2021
Completion date
December 31, 2026
Enrollment
150 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

burns